Cite
HARVARD Citation
Marchesi, F. et al. (2014). High incidence of post‐transplant cytomegalovirus reactivations in myeloma patients undergoing autologous stem cell transplantation after treatment with bortezomib‐based regimens: a survey from the Rome Transplant Network. Transplant infectious disease. 16 (1), pp. 158-164. [Online].